Bellerophon Provides Update on INOpulse Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Bellerophon Announces Results of Interim Analysis of Phase 3 INOvation-1 Study Evaluating INOpulse for Treatment of Pulmonary Arterial Hypertension
Aetherion to Demonstrate CNG Heavy-Duty, HPDI Powered Trucks, Supported by C$2 Million Funding from Fuel Innovation Fund